Waters Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021 While Fulgent's stock price nearly doubled, at the other end of the spectrum, Berkeley Lights saw an 80 percent decline in its share price. GW Index Rises 3 Percent in December Waters and Bio-Techne rebounded after falling in November, but Burning Rock and Genetron both saw sharp declines. Waters Q3 Revenues Rise 11 Percent Waters posted revenues of $659.2 million in Q3, compared to $593.8 million in Q3 2020 and beating the average Wall Street estimate of $656.5 million. Waters Q2 Revenues up 31 Percent The company posted revenues of $681.6 million, up 31 percent from $520.0 million in Q2 2020, and above the average Wall Street estimate of $621.5 million. Evercore ISI Upgrades Waters to Outperform Based on Improved Fundamentals The analysts cited opportunity in drug QC provided by Biogen's aducanumab approval as well as a new focus on markets like CROs and CDMOs. Jun 23, 2021 Waters, SISCAPA Assay Technologies Develop Mass Spec Test for SARS-CoV-2 Premium Jun 18, 2021 New Mass Spec Releases Target Single-Cell, Imaging Proteomics Work Premium May 28, 2021 New Products Posted to GenomeWeb: Fluidigm, Waters, MicroGenDx, More May 11, 2021 Sciex, Waters Partner to Provide Interoperable LC-MS Systems May 5, 2021 Waters Posts 31 Percent Increase in Q1 Revenues Mar 4, 2021 Waters Enters $500M Senior Notes Private Placement Feb 2, 2021 Waters Revenues up 10 Percent in Q4, Down 2 Percent in 2020 Jan 13, 2021 JP Morgan Healthcare Conference 2021, Day 2: Qiagen, Invitae, Agilent, Sema4, More Oct 27, 2020 Waters Q3 Revenues Up 3 Percent Jul 28, 2020 Waters Q2 Revenues Fall 13 Percent, Beat Wall Street Estimate Jul 15, 2020 Waters Reports Preliminary Q2 Revenue Drop of 13 to 14 Percent, Names New CEO Jul 2, 2020 Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020 Jul 1, 2020 Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index Jun 19, 2020 People in the News: Geoffrey Oxnard, Christopher O'Connell, Thierry Bernard, More Jun 12, 2020 2020 ASMS Goes Virtual With Emphasis on Software, Workflow Advances Premium Apr 28, 2020 Waters Q1 Revenues Down 10 Percent Feb 4, 2020 Waters Reports Flat Revenues for Q4, 1 Percent Decline for 2019 Jan 15, 2020 The Decade in Proteomics: Most Significant New Instrumentation Premium Jan 2, 2020 In 2019, Gains in Throughput Position Proteomics for Future Clinical Impact Premium Oct 29, 2019 Waters Q3 Revenues Flat, Fall Short of Expectations Load More Breaking News Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering The Scan Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian. Fulgent Seeking Defamation Suit Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports. Speeding Gene-Edited Crops Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there. Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.